精神障碍女性的避孕管理
本文综述精神障碍女性避孕选择的有效性、副作用及对精神症状的影响,以美国CDC避孕医疗适用标准为框架。多数女性选择复方口服避孕药,长效可逆避孕措施使用率仅14%。所有方法对抑郁症女性可接受,激素避孕与抑郁风险关系存争议,但临床研究多显示使用者情绪症状率相似或更低。
要点
- 长效可逆避孕措施失败率低、安全性好、取出后生育力恢复快,但仅14%女性选择。
- 所有避孕方法对抑郁症女性可接受,但躯体共病可能决定特定类型。
- 氯氮平、抗惊厥药和圣约翰草与避孕药存在相互作用,其他精神药物相互作用罕见。
核心结论
- 主动管理精神疾病、避孕和妊娠可改善女性功能并优化精神与生殖健康。
研究设计与样本
- 综述,检索PsycINFO、PubMed、Embase和Scopus中精神疾病女性避孕管理的文献,以CDC避孕医疗适用标准为结构。
主要发现
- 多数女性选择复方口服避孕药,长效可逆避孕措施仅14%女性选择。
- 激素避孕对抑郁风险的影响存在争议,但临床研究和随机安慰剂对照试验一般报告使用者情绪症状率相似或更低。
- 精神药物与避孕药相互作用罕见,但氯氮平、抗惊厥药和圣约翰草例外。
关键数值与推荐
- 长效可逆避孕措施与低失败率、良好安全性、取出后快速恢复生育力和少禁忌证相关。
- 所有避孕方法对抑郁症女性可接受,但躯体共病可能决定特定类型。
临床怎么用
- 精神科医生应为需要避孕的女性提供决策支持,考虑避孕方法对精神症状的影响及药物相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mental health care for women includes decision support to prepare for major life events, including preconception planning for treatment during pregnancy and the postpartum period. The authors discuss contraceptive choices and their effectiveness, side effects, and impact on psychiatric symptoms. The Centers for Disease Control and Prevention's recommendations, Medical Eligibility Criteria for Contraceptive Use, provided the structure for review of contraceptive choices. METHODS: A search of PsycINFO, PubMed, Embase, and Scopus was conducted for publications on the management of contraception for women with mental illness. Publications were selected if they included, based on the authors' consensus, data supporting evidence-based care important for psychiatrists who treat women desiring contraceptives. RESULTS: The majority of women choose combined oral contraceptives. Although long-acting reversible contraceptives (implants, intrauterine devices) are associated with low failure rates, favorable safety profiles, rapid return to fertility after removal, and few contraindications, they are chosen by only 14% of women. All methods are acceptable for women with depression, although medical comorbidities may dictate a specific type. The impact of hormonal contraceptives on the risk for depression is controversial; however, clinical studies and randomized placebo-controlled trials of women with psychiatric disorders have generally reported similar or lower rates of mood symptoms in hormonal contraceptive users compared with nonusers. Although interactions between psychotropic drugs and contraceptives are rare, clozapine, anticonvulsants, and St. John's Wort are exceptions. CONCLUSIONS: Proactive management of mental illness, contraception, and pregnancy improves a woman's capacity to function and optimizes her mental and reproductive health.
引用
- McCloskey LR, Wisner KL, Cattan MK, et al. Contraception for Women With Psychiatric Disorders. Am J Psychiatry. 2020. PMID: 33167674. doi:10.1176/appi.ajp.2020.20020154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。